Our firm advised Proklean Technologies Private Limited and its promoters in relation to the acquisition of 17.99% shares of Proklean by Greenstone Fund Scheme I.
This transaction involved a secondary sale of shares from existing shareholders and promoters to Greenstone. Proklean is a leading chemical manufacturing company engaged in the business of developing, manufacturing and selling non-toxic and biodegradable formulations based on probiotic technology. [1]
INDUSLAW Team:
Revathy Murali (Partner), Anurag Prasad (Senior Associate), Aryan Mohindroo (Associate) and Ayushi Suman (Associate).
Other law firms involved:
- Samvad Partners